大西 秀哉

Medicine & Life Sciences

1. Pancreatic Neoplasms 100%
2. Neoplasms 95%
3. Dendritic Cells 84%
4. Immunotherapy 80%
5. Adenocarcinoma 63%
6. Hypoxia 63%
7. T-Lymphocytes 61%
8. Lymphocytes 54%
9. Monocytes 51%
10. tropomyosin kinase 46%
11. Non-Receptor Type 3 Protein Tyrosine Phosphatase 40%
12. gemcitabine 37%
13. Regulatory T-Lymphocytes 34%
14. Breast Neoplasms 32%
15. Therapeutics 31%
16. Small Cell Lung Carcinoma 24%
17. N',N''-diacetylspermine 24%
18. Gallbladder Neoplasms 24%
19. Hedgehogs 23%
20. Phenotype 22%
21. Small Interfering RNA 22%
22. Carcinoma 22%
23. Neoplastic Stem Cells 21%
24. Vaccines 21%
25. Colorectal Neoplasms 21%
26. Epithelial Cell Adhesion Molecule 20%
27. Brain-Derived Neurotrophic Factor 20%
28. Picibanil 19%
29. Exosomes 19%
30. cyclopamine 19%
31. In Vitro Techniques 19%
32. Up-Regulation 19%
33. Active Immunotherapy 18%
34. Non-Small Cell Lung Carcinoma 18%
35. Lung 18%
36. Cell Line 17%
37. Peptides 17%
38. Cytokines 17%
39. catumaxomab 16%
40. Cytotoxic T-Lymphocytes 16%
41. Neuroendocrine Tumors 16%
42. Large Cell Carcinoma 16%
43. Neuroendocrine Carcinoma 15%
44. ONO-7579 15%
45. Antigen Presentation 15%
46. Neoplasm Metastasis 15%
47. Hedgehog Proteins 14%
48. Survival 14%
49. Triple Negative Breast Neoplasms 14%
50. Tumor Microenvironment 14%